Congress passes Trump’s megabill featuring historically steep Medicaid cuts

Podcast The Directors

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.

By Claire Marie Porter and Paul Goldberg

Guest Editorial

Lazarex Cancer Foundation set to close its doors Dec. 31
Can health nonprofits survive in the current environment?

As every non-profit organization knows, it is our obligation to be purpose-driven. Most NPO founders and the people who work for them have been thrown into this space as a result of life experiences. It is our passion rather than a job to simply collect a paycheck.

By Erin Miller

Cancer Policy

Trump backs off the 100% pharma tariffs ultimatum

President Donald Trump had threatened pharmaceutical companies with a 100% tariff, with an ultimatum set for Oct. 1.

Cancer Policy

United for Medical Research report shows NIH funding benefits patients, researchers

United for Medical Research conducted a report surveying patients and researchers on why NIH, and NIH funding matters to them.

Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.

October 03, 2025

Vol.51 No.36